<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-pharmaceuticals-13-00283">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alberti</surname>
    <given-names>T.B.</given-names>
   </name>
   <name>
    <surname>Barbosa</surname>
    <given-names>W.L.</given-names>
   </name>
   <name>
    <surname>Vieira</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Raposo</surname>
    <given-names>N.R.</given-names>
   </name>
   <name>
    <surname>Dutra</surname>
    <given-names>R.C.</given-names>
   </name>
  </person-group>
  <article-title>(-)-beta-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis</article-title>
  <source>Int. J. Mol. Sci.</source>
  <year>2017</year>
  <volume>18</volume>
  <elocation-id>691</elocation-id>
  <pub-id pub-id-type="doi">10.3390/ijms18040691</pub-id>
  <?supplied-pmid 28368293?>
  <pub-id pub-id-type="pmid">28368293</pub-id>
 </element-citation>
</ref>
